BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 28595743)

  • 1. The role of the complement system in hereditary angioedema.
    Csuka D; Veszeli N; Varga L; Prohászka Z; Farkas H
    Mol Immunol; 2017 Sep; 89():59-68. PubMed ID: 28595743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary angioedema due to C1-inhibitor deficiency in Macedonia: clinical characteristics, novel SERPING1 mutations and genetic factors modifying the clinical phenotype.
    Grivčeva-Panovska V; Košnik M; Korošec P; Andrejević S; Karadža-Lapić L; Rijavec M
    Ann Med; 2018 May; 50(3):269-276. PubMed ID: 29513108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of hereditary angioedema.
    Canonica GW; Rossi O
    Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of Hereditary Angioedema Revisited.
    Germenis AE; Speletas M
    Clin Rev Allergy Immunol; 2016 Oct; 51(2):170-82. PubMed ID: 27116602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
    Zeerleder S; Levi M
    Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Complement in Hereditary Angioedema.
    Levi M; Cohn DM
    Transfus Med Rev; 2019 Oct; 33(4):243-247. PubMed ID: 31676220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletions in SERPING1 Lead to Lower C1 Inhibitor Function: Lower C1 Inhibitor Function Can Predict Disease Severity.
    Mete Gökmen N; Gülbahar O; Onay H; Peker Koc Z; Özgül S; Köse T; Gelincik A; Büyüköztürk S; Sin AZ
    Int Arch Allergy Immunol; 2019; 178(1):50-59. PubMed ID: 30278448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition and classification of hereditary angioedema.
    Proper SP; Lavery WJ; Bernstein JA
    Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S03-S07. PubMed ID: 33109317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between complement levels and disease activity in Japanese family cases of hereditary angioedema with C1-INH deficiency.
    Fukunaga A; Tsuchiyama S; Lee K; Washio K; Hashimura C; Horiuchi T; Nishigori C
    Allergol Int; 2018 Oct; 67(4):518-520. PubMed ID: 29661499
    [No Abstract]   [Full Text] [Related]  

  • 10. High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency.
    Suffritti C; Zanichelli A; Maggioni L; Bonanni E; Cugno M; Cicardi M
    Clin Exp Allergy; 2014 Dec; 44(12):1503-14. PubMed ID: 24552232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
    Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
    Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angioedema Without Wheals: Challenges in Laboratorial Diagnosis.
    Grumach AS; Veronez CL; Csuka D; Farkas H
    Front Immunol; 2021; 12():785736. PubMed ID: 34956216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
    Joseph K; Tholanikunnel TE; Kaplan AP
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnosis and management of hereditary angioedema in a Greek family.
    Papadopoulou-Alataki E; Foerster T; Antari V; Pavlitou-Tsiontsi A; Varlamis G
    Int Arch Allergy Immunol; 2008; 147(2):166-70. PubMed ID: 18535392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
    Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
    Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment.
    Magerl M; Germenis AE; Maas C; Maurer M
    Immunol Allergy Clin North Am; 2017 Aug; 37(3):571-584. PubMed ID: 28687110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology.
    Sinnathamby ES; Issa PP; Roberts L; Norwood H; Malone K; Vemulapalli H; Ahmadzadeh S; Cornett EM; Shekoohi S; Kaye AD
    Adv Ther; 2023 Mar; 40(3):814-827. PubMed ID: 36609679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema.
    Deroux A; Boccon-Gibod I; Fain O; Pralong P; Ollivier Y; Pagnier A; Djenouhat K; Du-Thanh A; Gompel A; Faisant C; Launay D; Bouillet L
    Clin Exp Immunol; 2016 Sep; 185(3):332-7. PubMed ID: 27271546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary angioedema: Historical aspects, classification, pathophysiology, clinical presentation, and laboratory diagnosis.
    Khan DA
    Allergy Asthma Proc; 2011; 32(1):1-10. PubMed ID: 21262092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema.
    Piras V; Alves F; Gonçalo M
    Dermatol Ther; 2019 Nov; 32(6):e13098. PubMed ID: 31579975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.